期刊文献+

中国药品价格和数量指数及偏倚的实证分析 被引量:6

Empirical Analysis on Price Index,Quantity Index and Gerschenkron Effect in China
原文传递
导出
摘要 本文利用我国三个城市样本医院的招标采购数据,测算了2002~2005年抗生素类和循环系统药品价格和数量水平的变化趋势,并检验了Gerschenkron效应。结果显示,我国城市间的医疗模式具有较大差异,北京市使用品种比较集中,佛山市比较分散;抗生素类药品价格下降,循环系统类药品价格上升;4年间药品数量上升了许多倍。尤其是北京市,抗生素类上升了4倍多,循环系统类上升了9倍多,表明药品使用数量的增长是药品费用增长的主要贡献者。另外2004年和2005年我国药品价格和数量之间存在正相关关系,这是不符合市场正常供求状态的一种现象,说明我国药品价格决策机制中存在的某些力量干扰了正常的市场机制发挥作用,扭曲了市场的供求状况。 The paper calculated price index and quantity index of antibiotic drugs and circulation drugs for 2002-2005 using bidding data from hospital samples of 3 cities in China. Also, the Gerschenkron effect was inspected by the paper. The results showed that there were big difference in drug using pattern among different cities, which was Beijing market had few drugs and Foshan had more drugs; the price level of antibiotic drugs decreased and the price level of circulation drugs increased; quantity index showed that during 4 years quantity increased abnormality. Specially, the quantity of antibiotic drugs increased 4 times and circulation drugs increased 9 times in Beijng. This indicated that the main contribution of drug expenditure was drug quantity. There were positive correlation between drug price and quantity in China. This was not accord with demand theory, indicated that certain strengths distorted market supply and demand.
作者 吴晶 刘国恩
出处 《中国药物经济学》 2011年第1期7-17,共11页 China Journal of Pharmaceutical Economics
关键词 药品 价格 数量 指数 偏倚 drugs price quantity index bias
  • 相关文献

参考文献13

  • 1田文华,胡善联,王锦福,金春林,孙忆平,彭林森.医院常用药品物价指数研究Ⅰ──药品零售物价指数[J].中国卫生事业管理,1994,10(3):153-156. 被引量:3
  • 2刘国恩,唐艳.中国药品费用走势分析[J].中国卫生经济,2007,26(12):5-6. 被引量:18
  • 3韩晟,史录文.药品费用影响因素的指数体系方法研究[J].中国药物经济学,2008,0(6):62-67. 被引量:6
  • 4哈尔·范里安.微观经济学:现代观点(第六版).上海:上海人民出版社,105-108.
  • 5Nutter,W G ~ On measuring Economic Growth.Journal of Political Economy,1957,65 (1):51-63.
  • 6Morsteen,R A.On Measuring Productive Potential and Relative Efficiency.Quarterly Journal of Economics,1961,75(03):451-467.
  • 7Gerschenkron,A.The soviet indices of industrial production.Review of Economics and Statistics,1947,34:217-226.
  • 8Jonas P,Sardy H.The Gerschenkron effect:a re-examination.Review of Economics and Statistics,1972,52:82-86.
  • 9Danzon P M,Chao Li-Wei.Cross-national price differences for pharmaceuticals:how large,and why? Journal of Health Economics,2000,19:159-195.
  • 10.中国统计年鉴[M].,1999.269.

二级参考文献8

  • 1陈文,程晓明.药品价格指数编制的方法学探讨[J].中国卫生经济,1995,14(8):29-31. 被引量:9
  • 2Antonio A, Nicola M. New approaches to analyzing prescription data and to transfer pharmacoepidemiological and evidence-based reports to prescribers [J ]. Pharmacoepidemiology and Drug Safety, 2002 ( 11 ) : 721-726.
  • 3中华人民共和国卫生部.卫生政务通报(2007年5月)[J/OL].www.moh.gov.cn.
  • 4Dubois RW, Chawla AJ, Neslusan CA, et al. Explaining drug spending trends: does perception mateh reality[J ]. Health Affairs, 2000(19) :231-239.
  • 5Morgan SG. Quantifying components of drug expenditure inflation: the British Columbia seniors' drug benefit plan[J]. Health Services Research, 2002(37) : 1243-1266.
  • 6Berndt ER. Pharmaceuticals in U.S. health care: determinants of quantity and prices [J]. Journal of Economic Perspectives, 2002(16): 45-66.
  • 7蒋天文,樊志宏.中国医疗系统的行为扭曲机理与过程分析[J].经济研究,2002,37(11):71-80. 被引量:47
  • 8孟庆跃,成刚,孙晓杰.药品价格政策对药品费用控制的影响研究[J].中国卫生经济,2004,23(4):50-52. 被引量:36

共引文献116

同被引文献54

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部